Pharmaceutical business in the EAEU countries

Pharmaceutical business in the countries of the Eurasian Economic Union (EAEU) is developing within integrated market and regulatory structures, which facilitates trade and cooperation in pharmaceuticals. Our website offers articles discussing key aspects of the pharmaceutical industry in these countries, including common standards and quality requirements for medicines.

Explore how the EAEU promotes the harmonization of pharmaceutical regulations between member states by simplifying the drug registration process and mutual recognition of pharmaceutical products. Learn about the impact of these measures on the availability of medicines and how they stimulate local production and innovation. Get information on current and future projects aimed at improving the pharmaceutical sector in the region and increasing its competitiveness in the global market.

eaeu unified pvg inspection rules delta medical

EEC Council Adopts Uniform Rules for Pharmacovigilance Inspections in EAEU

The Council of the Eurasian Economic Commission (EEC) has taken a significant step towards harmonizing the pharmaceutical regulatory landscape across the Eurasian Economic Union (EAEU) member states.  In a recent decision taken on 12 April 2024, the EEC Council supplemented Decision No. 83 dated 03.11.2016 with the Rules for conducting pharmaceutical inspections to ensure compliance […]

EEC Council Adopts Uniform Rules for Pharmacovigilance Inspections in EAEU Read More »

Kazakh customs broker

Expanded Customs Declaration Data Proposed for Pharmaceutical Imports into the EAEU

The Eurasian Economic Commission has proposed changes to customs declarations that would impact pharmaceutical companies shipping products into the EAEU market.

Expanded Customs Declaration Data Proposed for Pharmaceutical Imports into the EAEU Read More »

The EAEU has approved the procedure for labeling medicines

In accordance with the document, member states of the Eurasian Economic Union shall independently determine the list of medicinal products subject to labeling with means of identification, the date of introduction and procedure of labeling on their territory in accordance with this Decision and notify the Eurasian Economic Commission not later than 6 months prior to the date of introduction of labeling

The EAEU has approved the procedure for labeling medicines Read More »

Scroll to Top